数位生物製造市场：按类型、应用和地区划分

预计到2026年，数位生物製造市场规模为28亿美元，到2033年将达到87亿美元。预计从2026年到2033年，该市场将以18.5%的复合年增长率成长。

数位化生物製造被视为数位化生物技术的进一步发展。它能够基于预期产品品质和批次盈利等关键因素，实现即时製程优化。数位化生物製造软体能够提高设备的可靠性和可用性，同时降低维护成本。此外，它还能透过消除错误来提高效率。

数位化製造的优势包括：

• 增强的监控能力
• 资料收集和处理
• 连线功能
• 计算机处理能力
• 过程控制演算法
• 自动化

市场动态

数位化生物製造有助于提高现有製程和设施的生产效率和稳定性。利用新兴数位技术可以解决影响生物製造设施的关键挑战。因此，向智慧製造的转型和应用正在推动市场成长。数位化製造在价值链各个环节实现快速反应，进而降低维护成本，进而促进市场成长。数位技术实现的生产即时视觉化为关键决策提供更完善的信息，并加速创新。因此，数位化生物製造技术在製药和生物製药行业的应用日益广泛。製造商正透过采用物联网 (IoT) 和人工智慧 (AI) 等新技术来推动生产，这进一步强化了对数位化生物製造的需求。此外，製造自动化将为克服商业性成功所面临的诸多挑战提供重要机会。这将为近期市场成长创造巨大机会。

本报告的主要特点

• 本报告对全球数位生物製造市场进行了详细分析，包括预测期（2026-2033 年）的市场规模和复合年增长率，以 2025 年为基准年。
• 此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本节根据以下参数，介绍全球数位生物製造市场的主要企业：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球数位生物製造市场》报告面向该行业的众多相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球数位生物製造市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 抑制因子
  • 市场机会
• 影响分析
• 市场趋势
• 主要进展
• 产品核准
• 商业伙伴关係、企业合併
• 监理情势
• PEST分析
• 波特五力分析
• 流行病学
• 固体管道分析

第四章 数位生物製造市场：按类型划分（2026-2033 年）

• 製造技术
• 分析和过程控制技术
• 其他的

第五章：数位生物製造市场：按应用领域划分（2026-2033 年）

• 生物製程优化
• 生物製造过程的自动化和控制
• 其他的

第六章 数位生物製造市场：按地区划分（2026-2033 年）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • GCC
  • 以色列
  • 其他中东国家
• 非洲
  • 北非
  • 中非
  • 南非

第七章 竞争情势

• 热图分析
• 市占率分析
• 公司简介
  • 3M
  • ABB
  • Cytiva
  • Siemens
  • immersciobio
  • Sanofi
  • BIOMERIEUX
  • Agilent Technologies, Inc.
  • GE Healthcare
  • Culture Biosciences

第八章

• 参考
• 分析方法
• 关于 Coherent Market Insights

Digital Biomanufacturing Market is estimated to be valued at USD 2.8 Bn in 2026 and is expected to reach USD 8.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.5% from 2026 to 2033.

Digital biomanufacturing is consider as a potentially greater manifestation of digital biotechnology. Digital biomanufacturing offers real-time process optimization based on extremely valued factors like expected product quality and batch profitability. Digital biomanufacturing software improves asset dependability and availability while lowering maintenance costs. It helps to increase efficiency by elimating the errors.

Advantages of digital manufacturing includes:

• Increased Monitoring
• Data Collection and Handling
• Connectivity
• Computer power
• Process control algorithms
• Automation

Market Dynamics

Digital biomanufacturing helps to improve productivity and robustness of existing processes and facilities. Key issues affecting biomanufacturing facilities can be addressed with the use of new digital technologies. Thus, shift towards smart manufacturing, implementing smart manufacturing is driven the growth of market. Quicker turnaround across all levels of the value chain by digital manufacturing is leads to lowering maintenance costs. This in turn to drive the growth of market. Real-time production visibility made possible by digital technologies offers better information for making important decisions and accelerates innovation. Thus, digital biomanufacturing technology has increasingly use through pharmaceutical and biopharmaceutical industries. Manufacturers are implementing new technologies such as internate of things (IoT), artificial intelligence (AI) and among others to drive the production is strengthen the demand for digital biomanufacturing. Moreover, automation in manufacturing would provide substantial opportunities to overcome many of the challenges faced in commercial success. This in turn to create significant opportunity for market growth in near future

Key features of the study

• This report provides an in-depth analysis of the global digital biomanufacturing market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global digital biomanufacturing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMERIEUX, Agilent Technologies, Inc, GE Healthcare, Culture Biosciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global digital biomanufacturing market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global digital biomanufacturing market

Market Segmentation

• By Type
  • Manufacturing Technologies
  • Analytical and Process Control Technologies
  • Others
• By Application
  • Bioprocess Optimization
  • Biomanufacturing Process Automation and Control
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • 3M
  • ABB
  • Cytiva
  • Siemens
  • immersciobio
  • Sanofi
  • BIOMERIEUX
  • Agilent Technologies, Inc
  • GE Healthcare
  • Culture Biosciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Product Approval
• Collaboration/Merge/Acquisition
• Regulatory Landscape
• PEST Analysis
• Porter's Five Forces Analysis
• Epidemiology
• Robust Pipeline Analysis

4. Digital Biomanufacturing Market, By Type, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• Manufacturing Technologies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Analytical and Process Control Technologies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Digital Biomanufacturing Market, By Application, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Bioprocess Optimization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Biomanufacturing Process Automation and Control
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Digital Biomanufacturing Market, By Region, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• Company Profile
  • 3M
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • ABB
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Cytiva
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Siemens
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • immersciobio
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Sanofi
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • BIOMERIEUX
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • GE Healthcare
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Culture Biosciences
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
• Analyst Views

8. Section

• References
• Research Methodology
• About Us